Business & Finance
AstraZeneca commits $100 million to MedImmune Ventures
PharmaTimes (U.K.) Nov. 29, 2011
PTC and Roche sign $490M deal for muscular atrophy drugs
MedCityNews.com Nov. 29, 2011
Infinity receives $50 million from R&D partner Mundipharma
Mass High Tech (Boston) Nov. 29, 2011
Government & Legal News
Industry urges passage of bill to encourage Medicaid's generics use
National Journal Nov. 28, 2011
Canada also revokes Avastin's approval for breast cancer
The Globe and Mail (Toronto) Nov. 28, 2011
FDA accelerates review of Pfizer and Bristol's anti-coagulant Eliquis
The Wall Street Journal Nov. 30, 2011, Reuters Nov. 29, 2011
EU authorizes Komboglyze and widens approval of Onglyza
PharmaTimes (U.K.) Nov. 29, 2011
FDA OKs Watson's generic of birth control pill Yaz
The Wall Street Journal Nov. 29, 2011
Gilead obtains EU approval of combo HIV pill Eviplera
PharmaTimes (U.K.) Nov. 29, 2011
Onyx's blood cancer drug carfilzomib is accepted for FDA review
American City Business Journals Nov. 29, 2011
Pipeline/R&D News
Study will combine breast cancer drugs from Genentech and Galena
American City Business Journals Nov. 28, 2011
Search for AIDS cure is making a comeback
The New York Times (tiered subscription model) Nov. 28, 2011